Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares OutstandingWages, Salaries and Other
Ratios

Rhythm Pharmaceuticals (RYTM) Leases (2018 - 2025)

Historic Leases for Rhythm Pharmaceuticals (RYTM) over the last 8 years, with Q3 2025 value amounting to $3.2 million.

  • Rhythm Pharmaceuticals' Leases fell 1198.44% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 1198.44%. This contributed to the annual value of $3.5 million for FY2024, which is 34519.85% up from last year.
  • Rhythm Pharmaceuticals' Leases amounted to $3.2 million in Q3 2025, which was down 1198.44% from $3.3 million recorded in Q2 2025.
  • Rhythm Pharmaceuticals' Leases' 5-year high stood at $3.7 million during Q2 2024, with a 5-year trough of $670000.0 in Q1 2024.
  • For the 5-year period, Rhythm Pharmaceuticals' Leases averaged around $1.9 million, with its median value being $1.5 million (2021).
  • In the last 5 years, Rhythm Pharmaceuticals' Leases plummeted by 3841.91% in 2024 and then skyrocketed by 40253.73% in 2025.
  • Over the past 5 years, Rhythm Pharmaceuticals' Leases (Quarter) stood at $1.5 million in 2021, then decreased by 22.34% to $1.2 million in 2022, then crashed by 33.93% to $781000.0 in 2023, then surged by 345.2% to $3.5 million in 2024, then decreased by 9.17% to $3.2 million in 2025.
  • Its Leases was $3.2 million in Q3 2025, compared to $3.3 million in Q2 2025 and $3.4 million in Q1 2025.